Abstract
Studies have evidenced that zinc metabolism is altered in the presence of Down syndrome, and zinc seems to have a relationship with the metabolic alterations usually present in this syndrome. In this work, the effect of zinc supplementation on thyroid hormone metabolism was evaluated in adolescents with Down syndrome. A prospective study was carried out on 16 adolescents with Down syndrome (age: 10–19 years) who were randomized for treatment with 30 mg zinc daily for 4 weeks. Diet evaluation was accomplished y using a 3-day dietary record, and the analysis was performed by the NutWin program, version 1.5. Anthropometric measurements were performed for evaluation of body composition. The Zn-related nutritional status of the groups was evaluated by means of zinc concentration determinations in plasma and erythrocytes using the method of atomic absorption spectroscopy, and the thyroid hormone was obtained by radioimmunoassay. The diet of patients with Down syndrome, before and after the intervention presented reduced energy level and adequate zinc concentrations. Mean plasma zinc values were 59.2 ± 13.2 and 71.0 ± 21.9 μg/dL before and after the intervention, respectively. Erythrocyte concentrations of the mineral before supplementation, instead, were 51.5 μg/dL ± 11.1 μg Zn/gHb, and at the end of the experiment, they were 42.9 ± 8/5 μg Zn/gHb, with a significant statistical difference (p < 0.05). Serum concentrations of T4 hormone before and after zinc supplementation were 1.26 ± 0.20 and 1.54 ± 0.63 pg/mL, respectively. Mean T3 values before intervention were 2.47 ± 037 pg/mL and, after supplementation, 2.25 ± 0.67 pg/mL, without significant statistical difference (p > 0.05). Intervention with zinc showed to be effective in the stabilization of the concentrations of this mineral in plasma and erythrocytes, but had no influence on the metabolism of thyroid hormones.
Similar content being viewed by others
References
Shapiro BL (1983) Down syndrome: a disruption of homeostasis. Am J Med Genet 14:241–269
Aguilar RH, Moraes TP, Moraes G (2003) Implicações do estresse oxidativo sobre o metabolismo eritrocitário de pessoas com síndrome de Down. Rev bras hematol hemoter 25:231–237
Groner Y, Elroy-Stein O, Avaraham KB (1994) Cell damage by excess Cu/Zn SOD and Down's sydrome. Biomed Pharmacother 48(5–6):231–240
Moreira LMA, El-Hani CN, Gusmão F (2000) A síndrome de Down e sua patogênese: considerações sobre o determinismo genético. Rev Bras Psiquiatr 22:96–99
Licastro F, Chiricolo M, Mocchegiani E, Fabris N, Zannoti M, Beltrandi E et al (1994) Oral zinc supplementation in Down’s Syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res 38:149–162
Kanavin OJ, Aaset J, Birketvedt GS (2000) Thyroid hypofunction in Dow’s syndrome: is it related to oxidative stress. Biol Trace Elem Res 78:35–42
Bucci I, Napolitano G, Giuliani C (1999) Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol Trace Elem Res 67:257–268
Sandströn B (1997) Bioavailability of zinc. Eur J Clin Nutr 1:S17–S19
Marreiro DN, Fisberg M, Cozzolino SMF (2004) Zinc nutritional status and its relationships with hyperinsulemia in obese children and adolescents. Biol Trace Elem Res 100:137–150
Romano C, Pettinato R, Ragusa L (2002) Is there a relationship between and the peculiar comorbities of Down syndrome? Downs Syndr Res Pract 8:25–28
Nishiyama S, Futagoishi-Suginohara Y, Matsukura M (1994) Zinc supplementation alters thyroid hormone metabolism in disabled patients with zinc deficiency. J Am Coll Nutr 13:62–67
Must A, Dalla G, Dietz WH (1991) Reference data for obesity: 85th and 95th percentiles of body mass index (wt/ht2) and triceps skin fold thickness. J Am Coll Nutr 53:839–846
Basiotis PP, Welsh SO, Cronin FT, Kelsay JL, Mertz W (1987) Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence. J Nutr 117:1638–1641
Anção MS, Cuppari L, Draibe AS, Sigulem D (2002) Programa de apoio à nutrição Nutwin: versão 1.5. São Paulo. Departamento de Informática em Saúde, SPDM, UNIFESP/ EPM, 1 CD-ROM.
Institute of Medicine/Food and Nutrition Board (2001) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, cooper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy, Washington, DC, p 650
Whitehouse RC, Prasad AS, Rabbani PI, Cossack ZT (1982) Zinc in plasma, neutrophils lymphocytes, and erythrocytes as determined by flameless atomic absorption spectrophotometry. Clin Chem 28:475–480
Rodriguez MP, Narizano A, Demczylo V, Cid A (1989) A simpler method for the determination of zinc human plasma levels by flame atomic absorption spectrophotometry. A.t. Spectrosc 10:68–70
Lopes TS (2005) Avaliação nutricional de crianças e adolescentes portadores de Síndrome de Down. Arq Bras End Metab 49:S525
Styles ME, Cole TJ, Dennis J, Preece MA (2002) New cross sectional stature, weight, and head circumference references for Down’s syndrome in the UK and Republic of Ireland. Arch Dis Chil 87:104–108
Luke A, Roizen MJ, Sutton M, Schoeller DA (1996) Nutrient intake and obesity prepubescent in children with Down syndrome. J Am Diet 96:1262–1267
Whittaker P (1988) Iron and zinc interactions in humans. Am J Clin Nutr 68:442S–446S
Teksen F, Saylin BS, Aydin A, Sayal A, Isimer A (1998) Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 63:123–127
Soto-Quintana A, Nava A, Atencio F, Granadillo A, Fernandez V, Ocando D (2003) Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down’s syndrome patients. Invest Clin 44:51–60
Marques RC, Sousa AF, Monte SJH, Oliveira FE, Nogueira NN, Marreiro DN (2007) Zinc nutritional status in adolescents with Down syndrome. Biol Trace Elem Res 120:8–11
Yenigun A, Ozkinay F, Cogulu O, Coker C, Cetiner N, Ozzlen G (2000) Hair zinc level in Down syndrome. Downs Syndr Res Pract 9:53–57
Gibson RS (1990) Assessment of trace—element status. In: Gibson RS (ed) Principles of nutritional assessment. Oxford Univ. Press, New York, pp 511–576 Principles of nutritional assessment. New York, Orford University, 1990, p 543–53
Zhou JR, Erdman JW (1995) Phytic acid in health and disease. Crit Rev Food Sci Nutr 35:495–508
Lönnerdal B (2000) Dietary factors influencing zinc absorption. J Nutr 130:1378–1383
Jackson MJ (1989) Physiology of zinc: general aspects. In: Mills CF (ed) Zinc in human biology. Springer, London, pp 323–333
Marques RC, Marrreiro DN (2006) Aspectos metabólicos e funcionais do zinco na síndrome de Down. Rev Nutr 19:501–510
Neve J, Sinet PM, Molle L, Nicole A (1983) Selenium, zinc and copper in Down’s syndrome (trisomy 21): blood levels and relations with glutathione peroxidase and superoxide dismutase. Clin Clim Acta 133:209–214
Purice M, Maximilian C, Duritriu I, Ioan D (1988) Zinc and copper in plasma and erythrocytes of Down’s children. Endocrinologie 26:113–117
Muchová J, Sustrová M, Garaiová I, Liptaková A, Blazicek P, Kvasnicka P, Pueschel S (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radical Biol Med 31:499–508
Lewis SM, Brain BJ, Bates I (2006) Eritrócitos. In: Hematologia Prática de Dacie e Lewis. Artmed, São Paulo, pp 45–46
Licastro F (2001) Immune-endocrine status and celiac disease in children with Down’s syndrome: relationships with zinc and cognitive efficiency. Brains Res Bull 55:313–317
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marreiro, D.d.N., de Sousa, A.F., Nogueira, N.d.N. et al. Effect of Zinc Supplementation on Thyroid Hormone Metabolism of Adolescents with Down Syndrome. Biol Trace Elem Res 129, 20–27 (2009). https://doi.org/10.1007/s12011-008-8280-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-008-8280-y